Skip to main content
. 2011 Mar;7(2):94–99. doi: 10.1200/JOP.2010.000046

Figure A2.

Figure A2.

Reasons for ordering the 21-gene recurrence score assay in patients with lymph node–positive, estrogen receptor–positive breast cancer. ER, estrogen receptor, PR, progesterone receptor, HER2, human epidermal growth factor receptor 2.